Dr. Suchi Saria on Building AI That Changes Care
Wednesday, August 19, 2026
Transcript intelligence
What OpenRounds heard
Source-grounded signals extracted from the episode transcript. Timestamps and supporting excerpts appear when available.
The speaker reports that running AI in the background at Johns Hopkins achieved a median 5.5 hours earlier sepsis detection compared to standard of care, with each hour associated with a 5-8% increased mortality risk.
“And what was really interesting was that we were able to show running AI in the background compared to standard of care at a place like Hopkins. There were patients who died who were coded for sepsis, and basically what we found is a median time of 5.5 hours earlier detection. In sepsis, every hour is associated with five to eight percent increased risk of mortality, so an hour can be the difference between life and death. And so 5.5 hours median time is nuts”
The speaker reports that Bayesian Health has implemented its sepsis AI tool across approximately 20 to 21 hospitals and 25 emergency departments within the Cleveland Clinic system.
The speaker reports that Bayesian Health partners with health systems to deploy AI at the point of care to augment frontline teams with a real-time clinical intelligence layer.
“And fast-forward, it's been so rewarding really partnering with the health systems around the country, deploying AI at the point of care to augment frontline teams with a real-time clinical intelligence layer that's really helping them cover what I think is a very big major open gap in most health systems' AI strategy today”
A patient can deteriorate while the warning signs remain buried in a noisy electronic record. Dr. Suchi Saria, Founder and CEO of Bayesian Health and a faculty member at Johns Hopkins University, has spent her career trying to surface those signals sooner. She explains why a strong retrospective model is only the starting point — and why prospective validation, workflow integration, physician adoption, monitoring, and financial sustainability determine whether clinical AI ever reaches patients. Her work on early sepsis recognition became personal after she lost her nephew to the condition, turning an academic agenda into an urgent effort to prevent failures to rescue. Saria also challenges the current center of gravity in health care AI: tools increasingly prepare for visits, transcribe conversations, and support billing, while comparatively few directly help clinicians care for patients. She envisions a third modality of medicine alongside drugs and devices — rigorous, software-based interventions that identify when to act, what to do, and for whom. Transcript. A patient can deteriorate while the warning signs remain buried in a noisy electronic record. Dr. Suchi Saria, Founder and CEO of Bayesian Health and a faculty member at Johns Hopkins University, has spent her career trying to surface those signals sooner. She explains why a strong retrospective model is only the starting point — and why prospective validation, workflow integration, physician adoption, monitoring, and financial sustainability determine whether clinical AI ever reaches patients. Her work on early sepsis recognition became personal after she lost her nephew to the condition, turning an academic agenda into an urgent effort to prevent failures to rescue. Saria also challenges the current center of gravity in health care AI: tools increasingly prepare for visits, transcribe conversations, and support billing, while comparatively few directly help clinicians care for patients. She envisions a thi
Show transcript excerpt
A patient can deteriorate while the warning signs remain buried in a noisy electronic record. Dr. Suchi Saria, Founder and CEO of Bayesian Health and a faculty member at Johns Hopkins University, has spent her career trying to surface those signals sooner. She explains why a strong retrospective model is only the starting point — and why prospective validation, workflow integration, physician adoption, monitoring, and financial sustainability determine whether clinical AI ever reaches patients. Her work on early sepsis recognition became personal after she lost her nephew to the condition, turning an academic agenda into an urgent effort to prevent failures to rescue. Saria also challenges the current center of gravity in health care AI: tools increasingly prepare for visits, transcribe conversations, and support billing, while comparatively few directly help clinicians care for patients. She envisions a third modality of medicine alongside drugs and devices — rigorous, software-based interventions that identify when to act, what to do, and for whom. Transcript.